Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anhedonia is associated with a specific depression profile and poor antidepressant response.
Luca A, Luca M, Kasper S, Pecorino B, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Messina A, Zanardi R, Ferri R, Tripodi M, Baune BT, Fanelli G, Fabbri C, Mendlewicz J, Serretti A. Luca A, et al. Among authors: serretti a. Int J Neuropsychopharmacol. 2024 Nov 10:pyae055. doi: 10.1093/ijnp/pyae055. Online ahead of print. Int J Neuropsychopharmacol. 2024. PMID: 39521954 Free article.
The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.
Schosser A, Carlberg L, Calati R, Serretti A, Massat I, Spindelegger C, Linotte S, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S. Schosser A, et al. Among authors: serretti a. Int J Neuropsychopharmacol. 2017 Oct 1;20(10):782-787. doi: 10.1093/ijnp/pyx028. Int J Neuropsychopharmacol. 2017. PMID: 28977521 Free PMC article.
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).
Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou GN, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S. Dold M, et al. Among authors: serretti a. Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009. Int J Neuropsychopharmacol. 2018. PMID: 29860382 Free PMC article.
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S. Dold M, et al. Among authors: serretti a. Eur Neuropsychopharmacol. 2018 Dec;28(12):1305-1313. doi: 10.1016/j.euroneuro.2018.10.003. Epub 2018 Nov 13. Eur Neuropsychopharmacol. 2018. PMID: 30446357
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression.
Fugger G, Dold M, Bartova L, Mitschek MMM, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Fabbri C, Frey R, Kasper S. Fugger G, et al. Among authors: serretti a. Int J Neuropsychopharmacol. 2020 Dec 3;23(9):571-577. doi: 10.1093/ijnp/pyaa035. Int J Neuropsychopharmacol. 2020. PMID: 32885810 Free PMC article.
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder.
Bartova L, Fugger G, Dold M, Kautzky A, Swoboda MMM, Rujescu D, Zohar J, Souery D, Mendlewicz J, Montgomery S, Fabbri C, Serretti A, Kasper S. Bartova L, et al. Among authors: serretti a. Int J Neuropsychopharmacol. 2022 Feb 11;25(2):118-127. doi: 10.1093/ijnp/pyab066. Int J Neuropsychopharmacol. 2022. PMID: 34637516 Free PMC article.
737 results